GlassScriptPhysician profile
Donald R Unwin
NPI 1407851157
$991.51
in general payments reported to CMS, 2019-2025
17 companies · $197 in 2025
The $197 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.89 · 2020: $113 · 2021: $124 · 2022: $122 · 2023: $245 · 2024: $107 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $292.33 | 2022-2025 | Clareon, Rocklatan, Argos |
| Johnson & Johnson Surgical Vision, INC. | $152.02 | 2023-2024 | Tecnis Iol, Tecnis Simplicity |
| Allergan, INC. | $110.86 | 2019-2021 | |
| Eyevance Pharmaceuticals LLC | $68.57 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $55.61 | 2019-2021 | |
| Amgen INC. | $44.32 | 2025 | Tepezza |
| Bausch & Lomb Americas INC. | $34.69 | 2022 | |
| Mallinckrodt Hospital Products INC. | $34.08 | 2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $33.60 | 2020 | |
| Glaukos Corporation | $32.62 | 2023 | |
| Abbvie INC. | $25.84 | 2024 | |
| Novartis Pharmaceuticals Corporation | $21.02 | 2020 | |
| Ocular Therapeutix, INC. | $19.25 | 2023 | Dextenza |
| Aerie Pharmaceuticals, INC. | $18.96 | 2021 | |
| Apellis Pharmaceuticals, INC. | $17.88 | 2024 | Syfovre |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.93 | 2019 | |
| Alimera Sciences, INC. | $14.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Unwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.